AMGN
- NASDAQ - DRUGS - Biotechnology
Amgen Inc
|
$190.39 |
-1.51 -0.79%
|
$194.18
|
$210.19
|
-9.42% |
1,589,580 50.75%
|
3,132,000
|
Most Recent Note for AMGN - 1/3/2019 12:39:46 PM
Sputtering near its 200 DMA line. Reported earnings +13% on +2% sales revenues for the Sep '18 quarter, and prior quarters were not strong and steady above the +25% minimum earnings guideline (C criteria). It has a slow and steady annual earnings (A criteria) history. Not a match with the fact-based investment system's fundamental guidelines.
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
AVGO
- NASDAQ - ELECTRONICS - Semiconductor - Integrated Circuits
Broadcom Inc
|
$237.26 |
-16.25 -6.41%
|
$246.54
|
$274.26
|
-13.49% |
2,511,239 64.06%
|
3,920,000
|
Most Recent Note for AVGO - 1/3/2019 12:40:52 PM
Abruptly pulling back near its 50 and 200 DMA lines. Prior mid-day reports noted - "Went through a choppy consolidation after dropped from the Featured Stocks list on 1/25/18, and it still faces resistance due to overhead supply up to the $285 level. Earnings increases have been mostly above the +25% minimum guideline (C criteria) in quarterly comparisons through Oct '18, but deceleration in its sales revenues growth rate has been noted."
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
BSTC
- NASDAQ - Medical-Biomed/Biotech
Biospecifics Technologie
|
$60.80 |
+0.81
1.35%
|
$61.10
|
$66.21
|
-8.17% |
20,240 51.90%
|
39,000
|
Most Recent Note for BSTC - 1/3/2019 12:43:03 PM
Thinly traded Biomed/Biotech firm is consolidating near its 50 DMA line. Earnings increases have been above the +25% minimum guideline (C criteria) in the 4 latest quarterly comparisons through Sep '18. Sales revenues growth showed acceleration, but quarterly totals have been in the $7-8 million range, still rather minuscule in the context of all publicly traded companies.
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
DORM
- NASDAQ - AUTOMOTIVE - Auto Parts
Dorman Products Inc
|
$87.45 |
-1.94 -2.16%
|
$89.20
|
$91.32
|
-4.24% |
160,042 86.51%
|
185,000
|
Most Recent Note for DORM - 1/3/2019 12:43:27 PM
Consolidated above its 50 DMA line in recent weeks and it is perched near its all-time high. Noted with caution in prior mid-day reports - "Fundamental concerns remain. Reported earnings +31% on +10% sales revenues for the Sep '18 quarter. Earnings results for prior quarters were not strong and steady above the +25% minimum guideline (C criteria) of the fact-based system."
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
GHC
- NYSE - Media-Diversified
Graham Holdings Co Cl B
|
$675.00 |
+22.16
3.39%
|
$675.53
|
$678.36
|
-0.50% |
15,863 66.10%
|
24,000
|
Most Recent Note for GHC - 1/3/2019 12:45:25 PM
Challenging its 52-week high with today's 2nd consecutive gain with above average volume. Found support at its 50 DMA line during its consolidation since last noted in the 11/28/18 mid-day report - "Recent quarterly comparisons through Sep '18 showed strong earnings increases, however, sub par sales revenues growth and its up and down annual earnings (A criteria) history leave fundamental concerns."
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
PLAB
- NASDAQ - ELECTRONICS - Semiconductor Equipment & Mate
Photronics Inc
|
$9.44 |
-0.35 -3.53%
|
$9.64
|
$11.00
|
-14.23% |
340,074 68.56%
|
496,000
|
Most Recent Note for PLAB - 1/3/2019 12:45:55 PM
Prior mid-day reports repeatedly noted - "Overhead supply up to the $13 level remains to act as resistance. Recent quarters through Oct '18 showed improving sales and great earnings increases well above the +25% minimum guideline (C criteria). Annual earnings history (A criteria) has been erratic and below guidelines."
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
RBA
- NYSE - DIVERSIFIED SERVICES - Business/Management Services
Ritchie Bros Auctioneers
|
$33.60 |
+0.65
1.97%
|
$33.83
|
$38.77
|
-13.34% |
440,510 120.03%
|
367,000
|
Most Recent Note for RBA - 1/3/2019 12:47:09 PM
Slumped below its 200 DMA line and undercut prior lows since last noted with caution in the 11/12/18 mid-day report - "The three latest quarterly comparisons through Sep '18 showed strong earnings increases. Up and down annual earnings (A criteria) history is not a match with the fact-based investment system's guidelines."
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
STOR
- NYSE - Finance-Property REIT
STORE Capital Corp
|
$27.99 |
+0.53
1.93%
|
$28.15
|
$31.05
|
-9.86% |
1,330,468 69.37%
|
1,918,000
|
Most Recent Note for STOR - 1/3/2019 12:47:59 PM
Finding support today near its 200 DMA line ($27.60) after a spurt of volume-driven losses. Reported Sep '18 earnings +15% on +24% sales revenues and fundamental concerns remain. Completed several new Public Offerings in recent years as this REIT rallied from its $19 IPO on 11/18/14.
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
THG
- NYSE - Insurance-Prop/Cas/Titl
Hanover Insurance Group
|
$114.83 |
-0.54 -0.47%
|
$115.04
|
$131.44
|
-12.64% |
215,775 90.28%
|
239,000
|
Most Recent Note for THG - 1/3/2019 12:48:40 PM
Fundamental concerns remain and it slumped below its 200 DMA line since noted in the 8/29/18 mid-day report with caution - "Prior quarterly and annual earnings history has not been a match with the fact-based investment system's guidelines (C and A criteria)."
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
WDFC
- NASDAQ - CHEMICALS - Specialty Chemicals
W D 40 Co
|
$178.16 |
+0.03
0.01%
|
$180.05
|
$187.50
|
-4.98% |
57,684 60.72%
|
95,000
|
Most Recent Note for WDFC - 1/3/2019 12:50:50 PM
Consolidating above its 50 DMA line after wedging to a new all-time high last week with gains lacking great volume conviction. The 11/14/18 mid-day report last noted - "Reported earnings +52% on +6% sales revenues for the Aug '18 quarter but fundamental concerns remain. Prior quarterly earnings increases were below the +25% minimum guideline (C criteria)."
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
WIRE
- NASDAQ - Electrical-Power/Equipmt
Encore Wire Corp
|
$49.96 |
-0.54 -1.07%
|
$50.44
|
$58.70
|
-14.89% |
39,063 51.40%
|
76,000
|
Most Recent Note for WIRE - 1/3/2019 12:53:52 PM
Reported earnings +69% on +17% sales revenues for the Sep '18 quarter, but fundamental concerns remain. Overhead supply remains and may hinder its progress up to the $58 level. Last noted with caution in the 2/28/18 mid-day report - "Erratic annual earnings (A criteria) history makes it a questionable candidate, fundamentally."
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|